Recommended content

Rescheduling could foster marijuana acceptance from health care industry

(This story is part of the cover package in the November-December issue of MJBizMagazine.)

Moving marijuana from Schedule 1 to Schedule 3 under the Controlled Substances Act could influence whether and how doctors recommend medical cannabis.

It also could have important ramifications for persuading insurance companies to pay for marijuana treatments for medical patients.


Currently, doctors do not prescribe state-regulated medical cannabis because they risk losing their licenses for prescribing something not approved by the U.S. Food and Drug Administration.

That would not change if the U.S. Drug Enforcement Administration reschedules marijuana: Doctors would still be barred from prescribing state-regulated MMJ products.

Doctors could, however, continue to recommend state-regulated, non-FDA-approved marijuana products to people seeking MMJ cards so they could register as cannabis patients with the state.

Prescribing changes

If the DEA moves cannabis to Schedule 3, doctors would be allowed to prescribe FDA-approved cannabis medicines.

That’s because physicians

Read full article on Marijuana Business Daily

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Business Daily

More news